FI902569A0 - Producering av till gonorre anslutande pi-proteiner och vaccin. - Google Patents
Producering av till gonorre anslutande pi-proteiner och vaccin.Info
- Publication number
- FI902569A0 FI902569A0 FI902569A FI902569A FI902569A0 FI 902569 A0 FI902569 A0 FI 902569A0 FI 902569 A FI902569 A FI 902569A FI 902569 A FI902569 A FI 902569A FI 902569 A0 FI902569 A0 FI 902569A0
- Authority
- FI
- Finland
- Prior art keywords
- gonorre
- anslutande
- producering
- proteiner
- vaccin
- Prior art date
Links
- 101710167885 Major outer membrane protein P.IB Proteins 0.000 abstract 3
- 206010018612 Gonorrhoea Diseases 0.000 abstract 2
- 241000588653 Neisseria Species 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/095—Neisseria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Plant Pathology (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI945110A FI101936B1 (fi) | 1987-11-24 | 1994-10-31 | Tippuribakteerien rokotteiden valmistusmenetelmä |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12472787A | 1987-11-24 | 1987-11-24 | |
US12472787 | 1987-11-24 | ||
US24275888A | 1988-09-09 | 1988-09-09 | |
US24275888 | 1988-09-09 | ||
PCT/US1988/004225 WO1989004873A1 (en) | 1987-11-24 | 1988-11-23 | Production of gonorrheal pi proteins and vaccines |
US8804225 | 1988-11-23 |
Publications (3)
Publication Number | Publication Date |
---|---|
FI902569A0 true FI902569A0 (fi) | 1990-05-23 |
FI102189B1 FI102189B1 (fi) | 1998-10-30 |
FI102189B FI102189B (fi) | 1998-10-30 |
Family
ID=26822891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI902569A FI102189B (fi) | 1987-11-24 | 1990-05-23 | Menetelmä tippuribakteerin PIA-proteiinin tuottamiseksi ja eristämisek si |
Country Status (12)
Country | Link |
---|---|
US (2) | US5736361A (fi) |
EP (2) | EP0869133A1 (fi) |
JP (2) | JP2803058B2 (fi) |
KR (1) | KR970011309B1 (fi) |
AT (1) | ATE169958T1 (fi) |
AU (1) | AU629807B2 (fi) |
CA (1) | CA1340506C (fi) |
DE (1) | DE3856240T2 (fi) |
DK (1) | DK175831B1 (fi) |
FI (1) | FI102189B (fi) |
NO (1) | NO302622B1 (fi) |
WO (1) | WO1989004873A1 (fi) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1340506C (en) * | 1987-11-24 | 1999-04-20 | Nicholas H. Carbonetti | Production of gonorrheal pi proteins and vaccines |
US7118757B1 (en) * | 1988-12-19 | 2006-10-10 | Wyeth Holdings Corporation | Meningococcal class 1 outer-membrane protein vaccine |
ATE174625T1 (de) * | 1991-03-14 | 1999-01-15 | Imclone Systems Inc | Rekombinante hybride porinepitope |
WO1995004133A1 (en) * | 1993-07-30 | 1995-02-09 | The University Of North Carolina At Chapel Hill | Production of gonorrheal pi proteins and vaccines in e. coli and salmonella |
US7252828B2 (en) | 1998-07-15 | 2007-08-07 | The Brigham And Women's Hospital, Inc. | Polysaccharide vaccine for staphylococcal infections |
MXPA01011499A (es) * | 1999-05-13 | 2002-06-04 | American Cyanamid Co | Formulaciones de combinacion de adyuvantes. |
ES2327895T3 (es) * | 1999-09-30 | 2009-11-05 | Isis Innovation Limited | Vacuna contra infeccion por neisseria. |
JP4763210B2 (ja) * | 2000-02-28 | 2011-08-31 | ノバルティス ヴァクシンズ アンド ダイアグノスティクス エスアールエル | ナイセリアのタンパク質の異種発現 |
AU2002225972B2 (en) * | 2000-11-10 | 2006-06-29 | Wyeth Holdings Corporation | Adjuvant combination formulations |
EP1583517B1 (en) | 2002-11-12 | 2019-06-12 | The Brigham And Women's Hospital, Inc. | Methods and products for treating staphylococcal infections |
PL229487B1 (pl) | 2002-11-12 | 2018-07-31 | Brigham & Womens Hospital Inc | Kompozycja zawierająca polimer β-1,6-glukozaminy, kompozycja zawierająca przeciwciało, kompozycja farmaceutyczna, sposób wytwarzania wyodrębnionego polisacharydu, sposób identyfikacji obecności deacetylowanej poli-N-acetyloglukozaminy (dPNAG) i/ lub poli-N-acetyloglukozaminy (PNAG), wyodrębniony polisacharyd do zastosowania w leczeniu lub profilaktyce zakażenia, wyodrębniony polisacharyd do zastosowania do wytwarzania przeciwciał, w tym przeciwciał monoklonalnych, wyodrębniony polisacharyd do zastosowania w identyfikacji przeciwciała monoklonalnego |
EP2455402A1 (en) | 2004-04-21 | 2012-05-23 | The Brigham and Women's Hospital, Inc. | Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof |
US7037698B2 (en) | 2004-05-19 | 2006-05-02 | Amano Enzyme Inc. | Pyrroloquinoline quinone-dependent glucose dehydrogenase |
CA2731384C (en) | 2008-07-21 | 2015-03-10 | The Brigham And Women's Hospital, Inc. | Methods and compositions relating to synthetic beta-1,6 glucosamine oligosaccharides |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4237224A (en) * | 1974-11-04 | 1980-12-02 | Board Of Trustees Of The Leland Stanford Jr. University | Process for producing biologically functional molecular chimeras |
US4203971A (en) * | 1978-03-23 | 1980-05-20 | Government Of The United States | Neisseria gonorrhoeae vaccine |
DE2814039C3 (de) * | 1978-03-31 | 1981-02-19 | Gesellschaft Fuer Biotechnologische Forschung Mbh (Gbf), 3300 Braunschweig | Verfahren zur Herstellung von Hybrid-Bakterien |
US4351761A (en) * | 1978-05-15 | 1982-09-28 | Research Corporation | Purified antigen to test for Neisseria gonorrhoeae antibodies |
US4220638A (en) * | 1978-10-12 | 1980-09-02 | Merck & Co., Inc. | Antigenic complex from N. Gonorrhoeae |
US4288557A (en) * | 1978-10-12 | 1981-09-08 | Merck & Co., Inc. | Antigenic complex from N. gonorrhoeae |
US4239749A (en) * | 1979-09-27 | 1980-12-16 | United States Of America | Neisseria gonorrhoeae vaccine |
FI63596C (fi) * | 1981-10-16 | 1983-07-11 | Orion Yhtymae Oy | Mikrobdiagnostiskt foerfarande som grundar sig pao skiktshybridisering av nukleinsyror och vid foerfarandet anvaenda kombinationer av reagenser |
WO1983003354A1 (en) * | 1982-03-30 | 1983-10-13 | Us Army | Neisseria gonorrhoeae vaccine |
EP0178863A1 (en) * | 1984-10-15 | 1986-04-23 | Schering Corporation | Novel expression systems utilizing bacteriophage T7 promoters and gene sequences |
US4681761A (en) * | 1985-10-24 | 1987-07-21 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University | Major iron-regulated protein of Neisseria gonorrhoeae and its use as vaccine |
US4786592A (en) * | 1986-06-18 | 1988-11-22 | Scripps Clinic And Research Foundation | Neisseria gonorrhoeae lectin useful as a vaccine and diagnostic marker and means for producing this lectin |
CA1340506C (en) * | 1987-11-24 | 1999-04-20 | Nicholas H. Carbonetti | Production of gonorrheal pi proteins and vaccines |
-
1988
- 1988-11-22 CA CA000583787A patent/CA1340506C/en not_active Expired - Fee Related
- 1988-11-23 JP JP1500595A patent/JP2803058B2/ja not_active Expired - Lifetime
- 1988-11-23 EP EP98101882A patent/EP0869133A1/en not_active Withdrawn
- 1988-11-23 AT AT89900540T patent/ATE169958T1/de not_active IP Right Cessation
- 1988-11-23 EP EP89900540A patent/EP0395706B1/en not_active Expired - Lifetime
- 1988-11-23 KR KR1019890701369A patent/KR970011309B1/ko not_active IP Right Cessation
- 1988-11-23 AU AU27959/89A patent/AU629807B2/en not_active Expired
- 1988-11-23 WO PCT/US1988/004225 patent/WO1989004873A1/en active IP Right Grant
- 1988-11-23 DE DE3856240T patent/DE3856240T2/de not_active Expired - Lifetime
-
1990
- 1990-05-22 NO NO902251A patent/NO302622B1/no unknown
- 1990-05-23 FI FI902569A patent/FI102189B/fi not_active IP Right Cessation
- 1990-05-23 DK DK199001284A patent/DK175831B1/da not_active IP Right Cessation
-
1992
- 1992-12-01 US US07/983,995 patent/US5736361A/en not_active Expired - Fee Related
-
1997
- 1997-11-06 US US08/965,085 patent/US6068992A/en not_active Expired - Fee Related
-
1998
- 1998-01-22 JP JP04415498A patent/JP3388171B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
JPH10234388A (ja) | 1998-09-08 |
FI102189B1 (fi) | 1998-10-30 |
DK128490A (da) | 1990-07-06 |
AU629807B2 (en) | 1992-10-15 |
NO902251L (no) | 1990-07-18 |
WO1989004873A1 (en) | 1989-06-01 |
JPH03502881A (ja) | 1991-07-04 |
AU2795989A (en) | 1989-06-14 |
DK175831B1 (da) | 2005-03-14 |
NO302622B1 (no) | 1998-03-30 |
ATE169958T1 (de) | 1998-09-15 |
US6068992A (en) | 2000-05-30 |
EP0869133A1 (en) | 1998-10-07 |
NO902251D0 (no) | 1990-05-22 |
KR970011309B1 (ko) | 1997-07-09 |
DK128490D0 (da) | 1990-05-23 |
JP3388171B2 (ja) | 2003-03-17 |
DE3856240D1 (de) | 1998-09-24 |
CA1340506C (en) | 1999-04-20 |
US5736361A (en) | 1998-04-07 |
KR890701750A (ko) | 1989-12-21 |
EP0395706A1 (en) | 1990-11-07 |
EP0395706A4 (en) | 1991-11-13 |
DE3856240T2 (de) | 1999-05-06 |
FI102189B (fi) | 1998-10-30 |
EP0395706B1 (en) | 1998-08-19 |
JP2803058B2 (ja) | 1998-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI902569A0 (fi) | Producering av till gonorre anslutande pi-proteiner och vaccin. | |
EP0192392A3 (en) | Insulin receptor, its purification, its production in recombinant cells, dna therefor, antibodies to insulin receptor and their preparation, and pharmaceutical compositions containing them | |
ATE181572T1 (de) | Ospa proteine von borrelia burgdorferi untergruppen, dafür kodierende gene sowie impfstoffe | |
FI101632B1 (fi) | Menetelmä Bordetella pertussis-toksiinin alayksikön analogien valmistamiseksi ja niitä koodaavia rekombinantti-DNA-molekyylejä | |
ATE120487T1 (de) | Therapeutische zusammensetzungen gegen streptokokken-infektionen, transformierte wirte, verfahren zur immunisierung und gentechnologisch hergestellte produkte. | |
RU94046017A (ru) | Нуклеиновые кислоты, вектор, клетка или трансгенный организм, синтетические полипептиды, способ получения синтетического пептида, вакцинная композиция, применение нуклеиновой кислоты, способ стимуляции иммунной реакции, олигосахарид | |
IL81018A (en) | Fusion proteins comprising small fragments of human interleukin-2 as ballast,process for its preparation and genes,vectors and transformed host containing said fragments and used in the process | |
SE8703539D0 (sv) | Artificiell gen och proteinprodukt | |
NZ500540A (en) | Purified proteins, fusion proteins, recombinant vector, vaccine, kit, comprising proteins from Actinobacillus pleuropneumoniae | |
CA2217522A1 (en) | Isolated frpb nucleic acid molecule and vaccine | |
FR2726472B1 (fr) | Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin | |
KR890700030A (ko) | 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법 | |
FI924457A (fi) | Kompositioner och behandlingsfoerfarande foer lunginflammation i djur | |
ATE89317T1 (de) | Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten. | |
SE8105516L (sv) | Syntetisk dna och forfarande for framstellning derav | |
DK38889D0 (da) | Onkogen-indkodet polypeptid med vaekstfaktoraktivitet | |
DE69839848D1 (de) | Nicht identische gene und ihre anwendung in verbesserten molekularen adjuvanten | |
SE8601940D0 (sv) | Preparation of fused proteins, antibodies and processes therefor | |
DK0629238T3 (da) | Autotaxin:Motilitetsstimulerende protein, som er nyttigt til cancerdiagnose og terapi | |
GR3036249T3 (en) | Coccidiosis poultry vaccine | |
DE69021886D1 (de) | Äusseres membranprotein p1 und peptide von haemophilus influenzae typ b. | |
DK595187A (da) | Minactivin og fremgangsmaade til fremstilling deraf | |
KR890002399A (ko) | 하이브리드 인터페론 및 재조합 dna기술을 이용한 그의 제조방법 | |
RU95101019A (ru) | Способ получения фактора некроза опухоли, фактор некроза опухоли, днк, клетка, композиция |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Patent granted |
Owner name: THE UNIVERSITY OF NORTH CAROLINA |
|
MA | Patent expired |